Thirty-two patients with coronary artery disease who underwent liver transplantation between 1990 and 1994 were identified. Coronary artery disease was managed medically (n = 9), by angioplasty (n = 1), or surgically (n = 22) prior to liver transplantation. Two patients underwent simultaneous corona
Cerebral blood flow and metabolism in patients with chronic liver disease undergoing orthotopic liver transplantation
β Scribed by Barbara J. Philips; Ian R. Armstrong; Anthony Pollock; Alistair Lee
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 103 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
Changes in cerebral hemodynamics and metabolism associated with anesthesia and liver transplantation may present particular hazards for patients with cirrhosis. Fifteen patients undergoing liver transplantation were studied, 7 of whom had encephalopathy. Cerebral blood flow (CBF) was measured at the start of surgery, during venovenous bypass and post reperfusion, using a method based on the Kety-Schmidt method. Cerebral metabolism was assessed by measuring the cerebral metabolic rate for oxygen (CMRO 2 ) and the lactate oxygen index (LOI). The cerebral vascular reactivity to carbon dioxide (CO 2 ) was studied during the preanhepatic and post reperfusion phases. During the preanhepatic period, the median CBF was 44 mL/100 g/min at an arterial carbon dioxide tension (PaCO 2 ) of 3.8 kPa. After reperfusion the CBF increased (P F .02) to 102 mL/100 g/min, the arterial hydrogen ion concentration increased from 39 nmol/L to 53 nmol/L (P F .02) and the jugular venous oxygen saturation from 74% to 89% (P F .02). CBF was similar in patients with and without encephalopathy. The cerebral vascular reactivity to CO 2 remained intact, although after reperfusion, the CBF for a given PaCO 2 was greater, and the slope of the CBF/CO 2 response curve diminished. The CMRO 2 was normal in patients without encephalopathy. In the encephalopathic patients, the CMRO 2 was low during all stages of transplantation (0.54, 0.86, 1.24 mL/100 g/min, respectively). Patients with encephalopathy may be at increased risk of hypoxemic brain injury during transplantation. To minimize this possibility, more detailed neurological monitoring may be useful. (HEPATOLOGY 1998;27:369-376.) Abbreviations: CBF, cerebral blood flow; PaCO 2 , arterial carbon dioxide tension; CO 2 , carbon dioxide; CMRO 2 , cerebral metabolic rate for oxygen; N 2 O, nitrous oxide; LOI, lactate oxygen index; TCD, transcranial doppler; kPa, kilopascal.
π SIMILAR VOLUMES
The current United Network for Organ Sharing (UNOS) policy is to allocate liver grafts to pediatric patients with chronic liver disease based on the pediatric end-stage liver disease (PELD) scoring system, while children with fulminant hepatic failure may be urgently listed as Status 1a. The objecti
with consequent organ dysfunction. Carnitine metabolism Carnitine metabolism was studied in 79 patients with could be disturbed by a variety of mechanisms in patients chronic liver disease, including 22 patients with noncirwith chronic liver disease. Dietary intake of carnitine could rhotic liver di
To examine the prevalence of hepatitis G virus (HGV) in end-stage liver disease of unknown cause and the role of HGV infection in posttransplantation hepatitis, we studied 46 patients undergoing liver transplantation (mean age, 50 years; M:F, 18:28) with cryptogenic cirrhosis. HGV RNA was detected b
Clinical significance of TT virus (TTV) infection was investigated in Egyptian patients with chronic liver disease and volunteer blood donors by a cross sectional analysis. TTV DNA in serum was assessed by a semi-nested polymerase chain reaction. The prevalence of TTV DNA did not differ among patien